ABOG Appoints New Board of Directors Members, Division Chair, and Members of Subspecialty Divisions

by NASDAQ Market News July 9, 2019

NASDAQ Market News
Click here to email author

Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma

Nanobiotix announces publication of phase III Soft Tissue Sarcoma data for first-in-class NBTXR3 in the Lancet Oncology

Ads